By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Obagi Medical Products, Inc. 

310 Golden Shore
1st Floor
Long Beach  California  90802  U.S.A.
Phone: 562-628-1007 Fax: 562-628-1008


SEARCH JOBS


Industry
Pharmaceutical

Segment
Research





Company News
Suneva Medical Announces an Expansion of Its ReGenica® Distribution Partnership With Obagi Medical Products, Inc. (OMPI) 10/29/2013 10:46:32 AM
Valeant Pharmaceuticals International (VRX) Completes Tender Offer for Obagi Medical Products, Inc. (OMPI) 4/25/2013 11:21:05 AM
Valeant Pharmaceuticals International (VRX) Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstanding Shares of Common Stock of Obagi Medical Products, Inc. (OMPI) 4/25/2013 9:11:49 AM
Valeant Pharmaceuticals International (VRX) Announces Receipt of Approval From the Antimonopoly Committee of Ukraine for Its Previously Announced Acquisition of Obagi Medical Products, Inc. (OMPI) 4/24/2013 10:09:22 AM
Valeant Pharmaceuticals International (VRX) Announces Receipt of Antitrust Clearance in the United States for Its Previously Announced Acquisition of Obagi Medical Products, Inc. (OMPI) 4/22/2013 11:01:56 AM
Merz Pharma Group Declines to Raise Bid for Obagi Medical Products, Inc. (OMPI), Yielding to Valeant Pharmaceuticals International (VRX) 4/8/2013 7:53:27 AM
Valeant Pharmaceuticals International (VRX) and Obagi Medical Products, Inc. (OMPI) Agree on an Increased Offer Price of $24.00 Per Share in Cash 4/3/2013 11:40:34 AM
Merz Pharma Group Offers $383.5 Million for Obagi Medical Products, Inc. (OMPI), Tops Deal Announced Last Month With Valeant Pharmaceuticals International (VRX) 4/2/2013 7:32:19 AM
Valeant Pharmaceuticals International (VRX) Agrees to Acquire Obagi Medical Products, Inc. (OMPI) for $344 Million 3/20/2013 7:28:40 AM
Obagi Medical Products, Inc. (OMPI) Reports Fourth Quarter and Year-End 2012 Financial Results 3/15/2013 6:26:48 AM
12345678910...
//-->